https://de.marketscreener.com/kurs/aktie/VIFOR-PHARMA-35018535/news/Vifor-Pharma-berichtet-uber-das-positive-Ergebnis-der-Phase-IIIb-Studie-mit-Veltassa-in-Diamond-37385813/?utm_source=telegram&utm_medium=social&utm_campaign=share